Open AccessP500: A REAL WORLD MULTI CENTRE STUDY OF CPX‐351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG‐IDA AND 3 + 7 IN HIGH RISK AML.
Author(s) -
Andrews C.,
AlNabhani I.,
Young T.,
Atenafu E. G.,
Assouline S. E.,
Brandwein J. M.,
Chan S. M.,
Chow S.,
Khalaf D.,
Gupta V.,
Kim D. D. H.,
Maze D.,
Minden M. M.,
Murphy T.,
Sanford D.,
Schimmer A. D.,
Schuh A. C.,
Sibai J.,
Yee K.,
Sibai H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844888.58115.a4
Subject(s) - medicine , oncology , flag (linear algebra) , cytarabine , daunorubicin , myeloid leukemia , chemotherapy , mathematics , pure mathematics , algebra over a field